431 related articles for article (PubMed ID: 28417162)
1. S100A6 protein: functional roles.
Donato R; Sorci G; Giambanco I
Cell Mol Life Sci; 2017 Aug; 74(15):2749-2760. PubMed ID: 28417162
[TBL] [Abstract][Full Text] [Related]
2. The Structure of the RAGE:S100A6 Complex Reveals a Unique Mode of Homodimerization for S100 Proteins.
Yatime L; Betzer C; Jensen RK; Mortensen S; Jensen PH; Andersen GR
Structure; 2016 Dec; 24(12):2043-2052. PubMed ID: 27818100
[TBL] [Abstract][Full Text] [Related]
3. Blocking the interface region amongst S100A6 and RAGE V domain via S100B protein.
Sung HY; Dowarha D; Chou RH; Yu C
Biochem Biophys Res Commun; 2020 Dec; 533(3):332-337. PubMed ID: 32958253
[TBL] [Abstract][Full Text] [Related]
4. S100B and S100A6 differentially modulate cell survival by interacting with distinct RAGE (receptor for advanced glycation end products) immunoglobulin domains.
Leclerc E; Fritz G; Weibel M; Heizmann CW; Galichet A
J Biol Chem; 2007 Oct; 282(43):31317-31. PubMed ID: 17726019
[TBL] [Abstract][Full Text] [Related]
5. S100A6 Regulates Endothelial Cell Cycle Progression by Attenuating Antiproliferative Signal Transducers and Activators of Transcription 1 Signaling.
Lerchenmüller C; Heißenberg J; Damilano F; Bezzeridis VJ; Krämer I; Bochaton-Piallat ML; Hirschberg K; Busch M; Katus HA; Peppel K; Rosenzweig A; Busch H; Boerries M; Most P
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1854-67. PubMed ID: 27386938
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of S100A6 promotes cell proliferation and migration in human hepatocellular carcinoma.
Li Z; Tang M; Ling B; Liu S; Zheng Y; Nie C; Yuan Z; Zhou L; Guo G; Tong A; Wei Y
J Mol Med (Berl); 2014 Mar; 92(3):291-303. PubMed ID: 24281831
[TBL] [Abstract][Full Text] [Related]
7. S100A6 as a potential serum prognostic biomarker and therapeutic target in gastric cancer.
Zhang J; Zhang K; Jiang X; Zhang J
Dig Dis Sci; 2014 Sep; 59(9):2136-44. PubMed ID: 24705642
[TBL] [Abstract][Full Text] [Related]
8. S100A6 represses Calu-6 lung cancer cells growth via inhibiting cell proliferation, migration, invasion and enhancing apoptosis.
Wang T; Han S; Du G
Cell Biochem Funct; 2021 Aug; 39(6):771-779. PubMed ID: 34008212
[TBL] [Abstract][Full Text] [Related]
9. Tubulin-dependent secretion of S100A6 and cellular signaling pathways activated by S100A6-integrin β1 interaction.
Jurewicz E; Wyroba E; Filipek A
Cell Signal; 2018 Jan; 42():21-29. PubMed ID: 29020611
[TBL] [Abstract][Full Text] [Related]
10. S100A6 - new facts and features.
Leśniak W; Słomnicki ŁP; Filipek A
Biochem Biophys Res Commun; 2009 Dec; 390(4):1087-92. PubMed ID: 19891957
[TBL] [Abstract][Full Text] [Related]
11. The Role of S100A6 in Human Diseases: Molecular Mechanisms and Therapeutic Potential.
Yang F; Ma J; Zhu D; Wang Z; Li Y; He X; Zhang G; Kang X
Biomolecules; 2023 Jul; 13(7):. PubMed ID: 37509175
[TBL] [Abstract][Full Text] [Related]
12. Circulating Ligands of the Receptor for Advanced Glycation End Products and the Soluble Form of the Receptor Modulate Cardiovascular Cell Apoptosis in Diabetes.
Tsoporis JN; Hatziagelaki E; Gupta S; Izhar S; Salpeas V; Tsiavou A; Rigopoulos AG; Triantafyllis AS; Marshall JC; Parker TG; Rizos IK
Molecules; 2020 Nov; 25(22):. PubMed ID: 33182705
[TBL] [Abstract][Full Text] [Related]
13. Lysozyme as the anti-proliferative agent to block the interaction between S100A6 and the RAGE V domain.
Khan MI; Dowarha D; Katte R; Chou RH; Filipek A; Yu C
PLoS One; 2019; 14(5):e0216427. PubMed ID: 31071146
[TBL] [Abstract][Full Text] [Related]
14. Interaction of the S100A6 mutant (C3S) with the V domain of the receptor for advanced glycation end products (RAGE).
Mohan SK; Gupta AA; Yu C
Biochem Biophys Res Commun; 2013 May; 434(2):328-33. PubMed ID: 23537648
[TBL] [Abstract][Full Text] [Related]
15. Effects of S100A6 gene silencing on the biological features of eutopic endometrial stromal cells and β‑catenin expression.
Zhang X; Liu Z; Chen M; Cao Q; Huang D
Mol Med Rep; 2017 Mar; 15(3):1279-1285. PubMed ID: 28075439
[TBL] [Abstract][Full Text] [Related]
16. The Calcium-Binding Protein S100A6 Accelerates Human Osteosarcoma Growth by Promoting Cell Proliferation and Inhibiting Osteogenic Differentiation.
Li Y; Wagner ER; Yan Z; Wang Z; Luther G; Jiang W; Ye J; Wei Q; Wang J; Zhao L; Lu S; Wang X; Mohammed MK; Tang S; Liu H; Fan J; Zhang F; Zou Y; Song D; Liao J; Haydon RC; Luu HH; He TC
Cell Physiol Biochem; 2015; 37(6):2375-92. PubMed ID: 26646427
[TBL] [Abstract][Full Text] [Related]
17. S100A6 is secreted from Wharton's jelly mesenchymal stem cells and interacts with integrin β1.
Jurewicz E; Góral A; Filipek A
Int J Biochem Cell Biol; 2014 Oct; 55():298-303. PubMed ID: 25256682
[TBL] [Abstract][Full Text] [Related]
18. S100 calcium-binding protein A6 promotes epithelial-mesenchymal transition through β-catenin in pancreatic cancer cell line.
Chen X; Liu X; Lang H; Zhang S; Luo Y; Zhang J
PLoS One; 2015; 10(3):e0121319. PubMed ID: 25799022
[TBL] [Abstract][Full Text] [Related]
19. S100A6 - focus on recent developments.
Leśniak W; Wilanowski T; Filipek A
Biol Chem; 2017 Sep; 398(10):1087-1094. PubMed ID: 28343163
[TBL] [Abstract][Full Text] [Related]
20. S100A6 (calcyclin) deficiency induces senescence-like changes in cell cycle, morphology and functional characteristics of mouse NIH 3T3 fibroblasts.
Słomnicki LP; Leśniak W
J Cell Biochem; 2010 Feb; 109(3):576-84. PubMed ID: 20013795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
